Addison Duda
Postdoctoral Scholar, Microbiology and Immunology
Honors & Awards
-
Dean's Postdoctoral Fellowship, Stanford University School of Medicine (01/2026–12/2026)
-
Joe Taylor Adams Fellowship, Department of Chemistry, Duke University (01/2025–05/2025)
-
Graduate Ambassador Fellowship, Department of Chemistry, Duke University (02/2025)
-
Burroughs Wellcome Fellowship, Department of Chemistry, Duke University (01/2024–05/2024)
-
NIH Pharmacological Sciences Training Program (T32 GM133352), Department of Pharmacology and Cancer Biology, Duke University (09/2021–08/2023)
Boards, Advisory Committees, Professional Organizations
-
Graduate-Alumni Representative, Trinity Board of Visitors, Duke University (2024 - Present)
-
Alumni Relations Chair, Department of Chemistry, Duke University (2023 - 2025)
-
Outreach Coordinator, Department of Chemistry, Duke University (2022 - 2024)
Professional Education
-
Ph.D., Duke University, Chemistry (2025)
-
Graduate Certificate, Duke University, Innovation and Entrepreneurship (2025)
-
B.S., Hope College, Chemistry, Biochemistry Emphasis: ACS-certified (2019)
All Publications
-
Cobalt(III) Schiff Base Complexes as Irreversible Inhibitors of the Metallo-β-Lactamase NDM-1.
ACS infectious diseases
2026; 12 (11): 3705-3717
Abstract
Antibiotic resistance is a critical public health concern, with approximately 2.8 million Americans infected with antibiotic-resistant bacteria annually and over 35,000 deaths in the United States alone. Of particular concern are Enterobacterales that express metallo-β-lactamases (MBLs), bacteria that cause nosocomial infections and exhibit resistance to most β-lactam drugs. The zinc-containing active sites of MBLs differ from those of serine β-lactamases, making current clinical inhibitors ineffective. No FDA-approved MBL inhibitors exist, leaving a critical gap in therapeutics for MBL-expressing Enterobacterales infections. Herein, we biochemically and spectroscopically demonstrate irreversible inhibition of the metallo-β-lactamase NDM-1 by a subset of cobalt(III) Schiff base complexes (Co(III)-sb). Crystallography and 59Co NMR experiments show that inactivation efficiency is dependent on axial and equatorial ligand identity. While Co(III)-sb exhibits NDM-1 inhibition, chemical modification is required to enable complexes to cross the Gram-negative envelope. These findings establish Co(III)-sb complexes as a novel scaffold for the development of MBL inhibitors.
View details for DOI 10.1021/acsinfecdis.6c00433
View details for PubMedID 43023865
-
Mechanistic insights into protein-mediated Zinquin fluorescence.
Comptes rendus. Chimie (Print)
2026; 29: 639-657
Abstract
Zinquin (ZQ) is a small-molecule fluorescent probe used to monitor labile zinc in biological systems based on green fluorescence emission arising from the formation of [Zn(ZQ)2]2- complexes. However, studies in cells and protein-rich environments frequently report a pronounced blue-shifted emission, suggesting alternative interaction modes that complicate the interpretation of zinc imaging experiments. The nature of the interactions driving the blue shift is not fully understood. Here, we use the metallo-β-lactamase NDM-1 as a chemically and structurally well-defined model to elucidate the molecular origins of ZQ fluorescence in a zinc-binding protein. The NDM-1 has two distinct Zn2+ ions in its active site, enabling direct assessment of zinc speciation, enzymatic activity, and structural integrity. Through an integrated approach combining fluorescence spectroscopy, enzyme activity assays, inductively coupled plasma mass spectrometry, X-ray absorption spectroscopy, and nuclear magnetic resonance, we identify two sources of ZQ fluorescence for this protein: formation of [Zn(ZQ)2]2- by stripping the weaker bound zinc, and a zinc-mediated ternary complex formed by NDM-1, Zn2+, and ZQ. This 1:1:1 complex localizes at the higher affinity zinc-binding site, where ZQ interacts concurrently with protein-bound zinc and specific residues of the NDM-1 active site. These nonpolar interactions generate a blue-shifted emission that is spectroscopically distinct from free zinc-ZQ complexes. This study characterizes the ternary complex that drives a protein-mediated fluorescence mechanism for ZQ and highlights the need to consider probe-protein interactions when interpreting fluorescent signals in chemical biology studies.
View details for DOI 10.5802/crchim.482
View details for PubMedID 43042023
View details for PubMedCentralID PMC13771970
-
An Engineered Prodrug Selectively Suppresses β-Lactam-Resistant Bacteria in a Mixed Microbial Setting.
ACS infectious diseases
2025
Abstract
The rise of β-lactam resistance necessitates new strategies to combat bacterial infections. We purposefully engineered the β-lactam prodrug AcephPT to exploit β-lactamase activity to selectively suppress resistant bacteria producing extended-spectrum-β-lactamases (ESBLs). Selective targeting of resistant bacteria requires avoiding interaction with penicillin-binding proteins, the conventional targets of β-lactam antibiotics, while maintaining recognition by ESBLs to activate AcephPT only in resistant cells. We show that AcephPT selectively suppresses Gram-negative ESBL-producing bacteria in clonal populations and in mixed microbial cultures, with effective selectivity for both lab strains and clinical isolates expressing ESBLs. Time-course NMR experiments confirm the hydrolytic activation of AcephPT exclusively by ESBL-producing bacteria. In mixed microbial cultures, AcephPT suppresses proliferation of an ESBL-producing strain while sustaining growth of β-lactamase-nonproducing bacteria, highlighting its potential to combat β-lactam resistance while promoting antimicrobial stewardship.
View details for DOI 10.1021/acsinfecdis.5c00179
View details for PubMedID 40503650
-
Mouse α-synuclein fibrils are structurally and functionally distinct from human fibrils associated with Lewy body diseases.
Science advances
2024; 10 (44): eadq3539
Abstract
The intricate process of α-synuclein aggregation and fibrillization holds pivotal roles in Parkinson's disease (PD) and multiple system atrophy (MSA). While mouse α-synuclein can fibrillize in vitro, whether these fibrils commonly used in research to induce this process or form can reproduce structures in the human brain remains unknown. Here, we report the first atomic structure of mouse α-synuclein fibrils, which was solved in parallel by two independent teams. The structure shows striking similarity to MSA-amplified and PD-associated E46K fibrils. However, mouse α-synuclein fibrils display altered packing arrangements, reduced hydrophobicity, and heightened fragmentation sensitivity and evoke only weak immunological responses. Furthermore, mouse α-synuclein fibrils exhibit exacerbated pathological spread in neurons and humanized α-synuclein mice. These findings provide critical insights into the structural underpinnings of α-synuclein pathogenicity and emphasize a need to reassess the role of mouse α-synuclein fibrils in the development of related diagnostic probes and therapeutic interventions.
View details for DOI 10.1126/sciadv.adq3539
View details for PubMedID 39485845
View details for PubMedCentralID PMC11800946
-
Anionic nanoplastic contaminants promote Parkinson's disease-associated α-synuclein aggregation.
Science advances
2023; 9 (46): eadi8716
Abstract
Recent studies have identified increasing levels of nanoplastic pollution in the environment. Here, we find that anionic nanoplastic contaminants potently precipitate the formation and propagation of α-synuclein protein fibrils through a high-affinity interaction with the amphipathic and non-amyloid component (NAC) domains in α-synuclein. Nanoplastics can internalize in neurons through clathrin-dependent endocytosis, causing a mild lysosomal impairment that slows the degradation of aggregated α-synuclein. In mice, nanoplastics combine with α-synuclein fibrils to exacerbate the spread of α-synuclein pathology across interconnected vulnerable brain regions, including the strong induction of α-synuclein inclusions in dopaminergic neurons in the substantia nigra. These results highlight a potential link for further exploration between nanoplastic pollution and α-synuclein aggregation associated with Parkinson's disease and related dementias.
View details for DOI 10.1126/sciadv.adi8716
View details for PubMedID 37976362
View details for PubMedCentralID PMC10656074
-
Intramolecular Oxidative Diaryl Coupling of Tetrasubstituted Diphenylamines for the Preparation of Bis(trifluoromethyl) Dimethyl Carbazoles
SYNOPEN
2021; 05 (04): 308-313
View details for DOI 10.1055/a-1662-7462
View details for Web of Science ID 000716699400001
https://orcid.org/0000-0002-8116-4714